共 103 条
[21]
Cervantes A(2014)Small (≤1-cm) hepatocellular carcinoma: diagnostic performance and imaging features at gadoxetic acid–enhanced MR imaging Radiology 271 748-760
[22]
Chau I(2018)Management of sub-centimeter recurrent hepatocellular carcinoma after curative treatment: current status and future World J Gastroenterol 24 5215-5222
[23]
Marrero JA(2010)The diagnostic and economic impact of contrast imaging techniques in the diagnosis of small hepatocellular carcinoma in cirrhosis Gut 59 638-644
[24]
Kulik LM(2018)Multidisciplinary management of recurrent and metastatic hepatocellular carcinoma after resection: an international expert consensus Hepatobiliary Surg Nutr 7 353-371
[25]
Sirlin CB(2016)Diagnostic criteria for hepatocellular carcinoma ⩽3 cm with hepatocyte-specific contrast-enhanced magnetic resonance imaging J Hepatol 64 1099-1107
[26]
Omata M(2020)Performance of gadoxetic acid MRI and diffusion-weighted imaging for the diagnosis of early recurrence of hepatocellular carcinoma Eur Radiol 30 186-194
[27]
Cheng AL(2018)Percutaneous US/MRI fusion-guided radiofrequency ablation for recurrent subcentimeter hepatocellular carcinoma: technical feasibility and therapeutic outcomes Radiology 288 878-886
[28]
Kokudo N(2008)MRI safety update 2008: part 1, MRI contrast agents and nephrogenic systemic fibrosis AJR Am J Roentgenol 191 1129-1139
[29]
Kudo M(2018)Detection of recurrent hepatocellular carcinoma after surgical resection: non-contrast liver MR imaging with diffusion-weighted imaging versus gadoxetic acid-enhanced MR imaging Br J Radiol 91 20180177-585
[30]
Matsui O(2020)Guidelines and good clinical practice recommendations for contrast enhanced ultrasound (CEUS) in the liver - update 2020 - WFUMB in cooperation with EFSUMB, AFSUMB, AIUM, and FLAUS Ultraschall Med 41 562-830